Fall 2026

Pharmacy Intern

Graduate

Posted on 8/14/2026

Deadline 10/24/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$23.75 - $42/hr

Company Historically Provides H1B Sponsorship

Portland, ME, USA

In Person

Occasional travel to other stores in the market may be needed.

PharmD

Category
Medical, Clinical & Veterinary (1)
Required Skills
Inventory Management
Word/Pages/Docs
Quality Assurance (QA)
Excel/Numbers/Sheets
Microsoft Outlook
PowerPoint/Keynote/Slides

Get referred to CVS Health

See people who can refer or advise you

Requirements
  • Be a PharmD graduate of a U.S.-accredited program before beginning the post-graduate training program.
  • Obtain required pharmacist licensure within the required timeframe under state guidelines; failure to obtain licensure within 120 days of graduation results in separation.
  • Possess, or be in the process of obtaining, valid intern and/or technician licensure as required.
  • Maintain regular and predictable attendance, including nights and weekends.
  • Complete required training within the designated timeframe.
  • Concentrate on tasks, pivot between tasks, and confirm prescription information and label accuracy to ensure patient safety.
  • Use mathematics to determine tablet quantities, days’ supply, and bottle requirements for prescriptions.
  • Resolve challenging patient or colleague interactions by selecting appropriate courses of action.
  • Meet the stated physical, visual, dexterity, lifting, mobility, and oral and written communication requirements.
  • Complete additional licensure and training requirements for Technician Immunizer status where permitted by law.
  • Perform other tasks as directed by a supervisor or manager.
Responsibilities
  • Apply pharmacy-school learning and pharmacy practice in real-world practice under the direction of a preceptor and District Leader.
  • Complete the comprehensive training roadmap within 120 days of graduation.
  • Follow company standard operating procedures and pharmacy workflow procedures at production, pick-up, drive-thru, and drop-off workstations.
  • Support safe, accurate, and prompt prescription fulfillment.
  • Serve patients at pick-up, drive-thru, and by telephone with empathy and personalized care.
  • Offer immunizations and other services where appropriate and solve or escalate patient problems.
  • Counsel patients, answer medical questions, and collect medical history under the direct supervision of a licensed pharmacist.
  • Take telephonic prescriptions and contact prescribers to clarify prescriptions or facilitate medication changes where allowed by state regulation.
  • Provide in-the-moment coaching, training, and mentoring to pharmacy team members while sharing best practices.
  • Complete basic inventory activities, including putting away medication deliveries, cycle counts, returns-to-stock, and waiting-bin inventories.
  • Comply with applicable laws, regulations, professional standards, ethical principles, and company policies, including controlled-substance dispensing and recordkeeping and patient privacy and security.
  • Deliver additional patient health care services, including immunizations, point-of-care testing, and staffing offsite clinics where allowable and trained.
  • Educate patients about vaccines, answer questions, and obtain informed consent.
  • Monitor and respond to adverse vaccine reactions and report events as required.
  • Review, collect, track, and document applicable patient information.
  • Travel voluntarily to stores in the market to work shifts as business needs require.
Desired Qualifications
  • At least 1 year of related work experience in a pharmacy, retail, medical, or customer-service setting.
  • Ability to become immunization certified after meeting state regulations.
  • Ability to work in the home store and across other market locations to meet business needs.
  • Proficiency in Microsoft Suite, including Outlook, Excel, Word, and PowerPoint.

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 5, 2026 Q2 revenue hit $106.1 billion, and adjusted EPS reached $2.58.
  • CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 and cash flow to $11.5 billion.
  • July 14, 2026 FTC settlement removed PBM litigation over rebates and network contracting.

What critics are saying

  • 340B lawsuits from Mount Sinai, Michigan, and Kansas seek hundreds of millions from CVS.
  • Pharmacy revenue depends on Rite Aid gains normalizing after 2025 bankruptcy acquisitions.
  • CVS carries $175 billion liabilities; PBM regulation could break the integration thesis by 2027.

What makes CVS Health unique

  • CVS integrates Aetna, Caremark, and 9,000 pharmacies into one consumer funnel.
  • August 5, 2026 Eli Lilly deal puts Zepbound pricing inside CVS Health app.
  • CVS's $20 billion AI program unifies claims, pharmacy, and care workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 14th, 2026
CVS Health beats Q2 revenue and profit estimates but faces questions on sustainability

CVS Health reported second quarter revenue of $106.1 billion, beating analyst estimates of $99.41 billion by 6.7%. Adjusted earnings per share came in at $2.58, surpassing expectations of $1.85 by 39.4%. Management attributed strong performance to specialty pharmacy and Medicare Advantage, with CEO David Joyner noting improvements from actions taken in Aetna and Caremark. The company raised its full-year adjusted EPS guidance to $8 at the midpoint. However, analysts raised concerns about sustainability. Management acknowledged ongoing challenges in the 340B program and normalisation of script share gains from Rite Aid. To offset these headwinds, executives pointed to biosimilars and investments in service technology. The company has committed $20 billion over a decade to AI and technology investments, with operational savings already being realised.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.

Yahoo Finance
Aug 11th, 2026
AbbVie acquires Apogee Therapeutics for $10.9B amid pipeline expansion

AbbVie has announced a $10.9 billion acquisition of Apogee Therapeutics in June 2026, aiming to strengthen its drug pipeline. The biopharmaceutical company reported FY 2025 revenue of nearly $61.2 billion, up roughly 8.6% year-on-year. Net income reached close to $4.2 billion, reflecting a net margin of approximately 6.9%, down from 7.6% the previous year. Free cash flow for the period was nearly $17.8 billion. CVS Health reported FY 2025 revenue of approximately $402.1 billion, representing growth of nearly 7.8%. The integrated healthcare provider serves around 37 million medical members and manages 1.9 billion prescriptions annually through its Health Services segment. Net income was close to $1.8 billion, yielding a net margin of roughly 0.4%, down from 1.2% in FY 2024.

Yahoo Finance
Aug 5th, 2026
CVS Health Q2 earnings beat expectations, partners with Eli Lilly on weight loss drugs

CVS Health reported second-quarter net income of $2.98 billion, or $2.31 per share, significantly beating analyst expectations of $1.85 per share. Revenue rose 7% to $106.10 billion, surpassing the forecast of $100.11 billion. The company raised its full-year adjusted earnings guidance to between $7.90 and $8.10 per share, up from $7.30 to $7.50 per share. Revenue guidance increased to at least $414 billion from $405 billion. CVS announced a partnership with Eli Lilly, with the CVS Health app to display pricing for Lilly's weight loss drugs Zepbound and Foundayo starting in early fourth quarter 2026. The company also reduced MinuteClinic virtual weight loss consultations to $29, eliminating membership fees.

PR Newswire
Aug 5th, 2026
CVS Health posts $106.1B Q2 revenue, raises full-year earnings guidance to $7.90-$8.10

CVS Health reported second quarter 2026 revenues of $106.1 billion, up 7.3% year-over-year. The company posted GAAP diluted earnings per share of $2.31 and adjusted EPS of $2.58, compared to $0.80 and $1.81 respectively in the prior year. The company raised its full-year 2026 guidance, increasing GAAP diluted EPS guidance to $6.84-$7.04 from $6.24-$6.44 and adjusted EPS guidance to $7.90-$8.10 from $7.30-$7.50. Cash flow from operations guidance was raised to at least $11.5 billion from at least $9.5 billion. CVS Health generated $10.6 billion in year-to-date cash flow from operations. The improved performance was primarily driven by the Health Care Benefits segment, reflecting continued execution on its margin recovery plan. The company operates approximately 9,000 retail pharmacy locations and serves around 87 million plan members through its pharmacy benefits manager.